KUALA LUMPUR (Oct 28): Alpha IVF Group Bhd (KL:ALPHA) posted a 6.3% jump in net profit to RM15.28 million for the first quarter ended Aug 31, 2025, from RM14.38 million a year earlier, driven by higher sales and improved margins. 

The group’s revenue was principally derived from the provision of assisted reproductive services focusing on in vitro fertilisation (IVF) treatments.

In a filing with Bursa Malaysia on Tuesday, Alpha IVF said it saw a 21.2% increase in revenue to RM52.10 million during the quarter under review compared with RM42.10 million previously. 

The company declared a second single-tier interim dividend of 0.5 sen per share, amounting to RM24.30 million, on July 28, 2025 in respect of the financial year ended May 31, 2025 (FY2025).

Alpha IVF plans to open two new IVF centres in Sabah and Johor next year, followed by two centres in the Philippines and two satellite offices in Indonesia, in line with Malaysia’s position as a leading medical tourism hub.

The group currently operates four full-fledged IVF centres in Malaysia and Singapore, two sales and representative offices in China, and two satellite clinics in Indonesia.

“Furthermore, the group has on Sept 30 signed a land lease agreement with state-owned entity PT Hotel Indonesia Natour to facilitate the development of a full-fledged IVF centre in the Sanur Special Economic Zone, Bali.

“Simultaneously, the group is strategically entering the Philippines to capitalise on a promising, yet underserved market. The group is planning to establish two full-fledged IVF centres in Manila and Tuguegarao to address the rising need for specialised reproductive care,” it added.

Alpha IVF shares closed 1.5% lower at 33.5 sen on Tuesday, valuing the group at RM1.63 billion.

Read also:
Alpha IVF keeps M&A option open, eyes Main Market transfer by early next year